Microfluidic Liposomal Adjuvant Manufacturing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for new manufacturing approaches that enable the safe, convenient, and cost-effective production of liposomal adjuvants on a commercially viable scale while maintaining immunological performance.
Innovation Solution
A microfluidic device is used to manufacture a liposomal adjuvant comprising a saponin by mixing a solution of solvent, phosphatidylcholine lipid, and sterol with a solution of water and saponin, followed by solvent removal, to produce a liposomal concentrate suitable for use in preparing a liposomal adjuvant.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional manufacturing methods are used to produce liposomal adjuvants, then production capacity and scalability are limited, but implementing new manufacturing approaches increases device complexity and process difficulty
Solution Approach 1:
The patent replaces conventional large-scale mechanical mixing and homogenization equipment with a microfluidic device that uses precise flow control and laminar flow dynamics to achieve lipid-saponin mixing and liposome formation. This substitution enables scalable production while maintaining controlled mixing conditions that are difficult to achieve with traditional mechanical systems.
Solution Approach 2:
The invention transitions from bulk-phase manufacturing to micro-scale flow dynamics by utilizing the third dimension of fluid flow in microchannels. The microfluidic device creates controlled laminar flow regimes and diffusion-driven mixing in a dimensionally constrained environment, enabling precise control over liposome formation that scales differently than conventional volume-based processes.
2Ease of manufacture
If conventional manufacturing methods are used, then production costs are high, but new methods require advanced microfluidic technology which increases initial investment
Solution Approach 1:
The patent changes the operating parameters from high-energy mechanical processing to low-flow-rate laminar flow conditions. By operating in the laminar flow regime with controlled Reynolds numbers, the microfluidic device achieves efficient mixing and liposome formation at lower energy input and potentially lower operational costs, offsetting the initial technology investment.
Solution Approach 2:
The replacement of expensive, high-maintenance mechanical homogenization equipment with a simpler microfluidic chip-based system reduces long-term operational costs. The microfluidic device requires minimal moving parts, reducing maintenance needs and operational expenses despite higher initial fabrication costs.
3Manufacturing precision
If conventional mixing methods are used to combine lipid and saponin solutions, then mixing homogeneity is insufficient, but enhanced mixing increases processing time
Solution Approach 1:
The patent replaces mechanical stirring and homogenization with diffusion-driven mixing in laminar flow. The microfluidic device design incorporates channel geometries that promote interfacial area maximization and diffusion efficiency, achieving homogeneous mixing of lipid and saponin solutions without the time-consuming mechanical processing required by conventional methods.
Solution Approach 2:
The invention uses hydraulic flow control through microchannels to achieve precise mixing. By controlling flow rates and channel dimensions, the system creates optimal conditions for molecular diffusion and convective mixing, achieving homogeneous distribution of components rapidly without mechanical intervention.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method allows for the production of liposomal adjuvants with comparable immunological performance to conventional methods, enabling scalable and efficient manufacturing while ensuring safety and reducing costs.
Implementation Method 1
mixing in the device a first solution comprising a solvent, phosphatidylcholine lipid and a sterol, and a second solution comprising water and the saponin
Implementation Method 2
removing the solvent
Data Source
AI summary
The present invention relates to compositions and methods for manufacturing an adjuvant comprising a saponin using a microfluidic device and to aspects thereof.